Schedule 13D ownership disclosure

ALDER BIOPHARMACEUTICALS INC

Security class unavailable · CUSIP: 014339105

Event date: 2018-04-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,807,876
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001425738-18-000022
Form type
SC 13D/A
Filer
ALDER BIOPHARMACEUTICALS INC
CIK
CIK 1423824
Filed
Apr 26, 2018
Reporting period
Apr 25, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub